Insider Buying Spurs Hope: Myriad’s Shares Rally on AI‑Driven Diagnostics and Strong Executive Support
Insider buys at $4.74 signal confidence in Myriad’s AI‑powered diagnostics and future growth, but regulatory and competitive risks still loom over its steeply discounted shares.
4 minutes to read